Bioventix (BVXP) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.305x

Based on the latest financial reports, Bioventix (BVXP) has a cash flow conversion efficiency ratio of 0.305x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX3.52 Million ≈ $428.34 USD) by net assets (GBX11.55 Million ≈ $1.41K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bioventix - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Bioventix's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Bioventix for a breakdown of total debt and financial obligations.

Bioventix Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioventix ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Anpario Plc LSE:ANP	0.037x
Lithium One Metals Inc V:LONE	-0.004x
SIG plc LSE:SHI	0.208x
MTI Investment SE ST:MTI	-0.062x
Lifeist Wellness Inc V:LFST	-0.325x
Metavisio (Thomson Computing) PA:ALTHO	0.002x
Tres Or Resources Ltd V:TRS	-0.004x
Hub Cyber Security Ltd. Ordinary Shares NASDAQ:HUBC	0.109x

Annual Cash Flow Conversion Efficiency for Bioventix (2011–2025)

The table below shows the annual cash flow conversion efficiency of Bioventix from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Bioventix market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX11.55 Million ≈ $1.41K	GBX7.03 Million ≈ $855.57	0.609x	-12.44%
2024-06-30	GBX12.00 Million ≈ $1.46K	GBX8.34 Million ≈ $1.02K	0.695x	+6.11%
2023-06-30	GBX12.06 Million ≈ $1.47K	GBX7.90 Million ≈ $961.62	0.655x	+2.42%
2022-06-30	GBX11.82 Million ≈ $1.44K	GBX7.56 Million ≈ $920.03	0.640x	+18.74%
2021-06-30	GBX11.82 Million ≈ $1.44K	GBX6.37 Million ≈ $774.79	0.539x	-12.67%
2020-06-30	GBX12.52 Million ≈ $1.52K	GBX7.72 Million ≈ $939.79	0.617x	+13.63%
2019-06-30	GBX10.83 Million ≈ $1.32K	GBX5.88 Million ≈ $715.12	0.543x	+0.94%
2018-06-30	GBX11.01 Million ≈ $1.34K	GBX5.92 Million ≈ $720.55	0.538x	+37.89%
2017-06-30	GBX10.14 Million ≈ $1.23K	GBX3.96 Million ≈ $481.44	0.390x	+0.93%
2016-06-30	GBX8.21 Million ≈ $998.60	GBX3.17 Million ≈ $385.91	0.386x	+18.62%
2015-06-30	GBX6.58 Million ≈ $801.10	GBX2.15 Million ≈ $260.99	0.326x	-3.36%
2014-06-30	GBX5.24 Million ≈ $637.09	GBX1.77 Million ≈ $214.78	0.337x	+5.70%
2013-06-30	GBX4.20 Million ≈ $511.61	GBX1.34 Million ≈ $163.17	0.319x	-14.04%
2012-06-30	GBX3.34 Million ≈ $406.34	GBX1.24 Million ≈ $150.76	0.371x	+29.66%
2011-06-30	GBX2.68 Million ≈ $325.76	GBX766.14K ≈ $93.22	0.286x	--

About Bioventix

LSE:BVXP UK Biotechnology

Market Cap

$1.10 Million

GBX9.01 Billion GBX

Market Cap Rank

#30150 Global

#785 in UK

Share Price

GBX1725.00

Change (1 day)

+0.00%

52-Week Range

GBX1375.00 - GBX3020.00

All Time High

GBX4868.77